Masuzaki H - Search Results

1

Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.

Ebihara K, Kusakabe T, Hirata M, Masuzaki H, Miyanaga F, Kobayashi N, Tanaka T, Chusho H, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, DePaoli AM, Fukushima M, Nakao K. Ebihara K, et al. Among authors: masuzaki h. J Clin Endocrinol Metab. 2007 Feb;92(2):532-41. doi: 10.1210/jc.2006-1546. Epub 2006 Nov 21. J Clin Endocrinol Metab. 2007. PMID: 17118991 Clinical Trial.

2

High-fat diet impairs the effects of a single bout of endurance exercise on glucose transport and insulin sensitivity in rat skeletal muscle.

Tanaka S, Hayashi T, Toyoda T, Hamada T, Shimizu Y, Hirata M, Ebihara K, Masuzaki H, Hosoda K, Fushiki T, Nakao K. Tanaka S, et al. Among authors: masuzaki h. Metabolism. 2007 Dec;56(12):1719-28. doi: 10.1016/j.metabol.2007.07.017. Metabolism. 2007. PMID: 17998027

3

Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy.

Iwanishi M, Ebihara K, Kusakabe T, Chen W, Ito J, Masuzaki H, Hosoda K, Nakao K. Iwanishi M, et al. Among authors: masuzaki h. Metabolism. 2009 Dec;58(12):1681-7. doi: 10.1016/j.metabol.2009.04.043. Epub 2009 Sep 29. Metabolism. 2009. PMID: 19793595

4

Gene and phenotype analysis of congenital generalized lipodystrophy in Japanese: a novel homozygous nonsense mutation in seipin gene.

Ebihara K, Kusakabe T, Masuzaki H, Kobayashi N, Tanaka T, Chusho H, Miyanaga F, Miyazawa T, Hayashi T, Hosoda K, Ogawa Y, Nakao K. Ebihara K, et al. Among authors: masuzaki h. J Clin Endocrinol Metab. 2004 May;89(5):2360-4. doi: 10.1210/jc.2003-031211. J Clin Endocrinol Metab. 2004. PMID: 15126564

5

Association of Ob-R gene polymorphism and insulin resistance in Japanese men.

Takahashi-Yasuno A, Masuzaki H, Miyawaki T, Matsuoka N, Ogawa Y, Hayashi T, Hosoda K, Yoshimasa Y, Inoue G, Nakao K. Takahashi-Yasuno A, et al. Among authors: masuzaki h. Metabolism. 2004 May;53(5):650-4. doi: 10.1016/j.metabol.2003.12.012. Metabolism. 2004. PMID: 15131772

6

[Novel transgenic mouse model of the metabolic syndrome].

Masuzaki H, Tanaka T, Nakao K. Masuzaki H, et al. Nihon Rinsho. 2004 Jun;62(6):1059-65. Nihon Rinsho. 2004. PMID: 15206142 Review. Japanese.

7

Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410.

Norisada N, Masuzaki H, Fujimoto M, Inoue G, Hosoda K, Hayashi T, Watanabe M, Muraoka S, Yoneda F, Nakao K. Norisada N, et al. Among authors: masuzaki h. Metabolism. 2004 Dec;53(12):1532-7. doi: 10.1016/j.metabol.2004.06.020. Metabolism. 2004. PMID: 15562395

8

[Obesity and the metabolic syndrome].

Masuzaki H, Nakao K. Masuzaki H, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:264-8. Nihon Rinsho. 2005. PMID: 15779384 Review. Japanese. No abstract available.

9

[Role of PPARs in the pathophysiology of nonalcoholoic fatty liver disease].

Tanaka T, Masuzaki H, Nakao K. Tanaka T, et al. Among authors: masuzaki h. Nihon Rinsho. 2005 Apr;63(4):700-6. Nihon Rinsho. 2005. PMID: 15828240 Review. Japanese.

10

Skeletal muscle AMP-activated protein kinase phosphorylation parallels metabolic phenotype in leptin transgenic mice under dietary modification.

Tanaka T, Hidaka S, Masuzaki H, Yasue S, Minokoshi Y, Ebihara K, Chusho H, Ogawa Y, Toyoda T, Sato K, Miyanaga F, Fujimoto M, Tomita T, Kusakabe T, Kobayashi N, Tanioka H, Hayashi T, Hosoda K, Yoshimatsu H, Sakata T, Nakao K. Tanaka T, et al. Among authors: masuzaki h. Diabetes. 2005 Aug;54(8):2365-74. doi: 10.2337/diabetes.54.8.2365. Diabetes. 2005. PMID: 16046303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page